#entrada-therapeutics
Latest news and interesting information about entrada-therapeutics.
Director Buys $29,316 in Stock
Entrada Therapeutics director Bernhardt Zeiher buys $29,316 in stock. Bond.az analysis shows the stock may be undervalued.
...
→
EN ▾
Peruvian artist's exhibition opens in BakuFirst Official MLS Broadcast with iPhone 17 ProRonaldo wins 35th trophy of his careerChemung Financial declares $0.34 dividendRevolution Medicines Phase 3 Results WebcastNoble appoints Halliburton CEO Jeff Miller to boardFlowers Foods Q1 2026 EPS Beat, Revenue MissDirector Buys $29,316 in StockLeyla & Arzu Aliyeva Visit Urban ExpoArm CFO sells $7.23 million in sharesPeruvian artist's exhibition opens in BakuFirst Official MLS Broadcast with iPhone 17 ProRonaldo wins 35th trophy of his careerChemung Financial declares $0.34 dividendRevolution Medicines Phase 3 Results WebcastNoble appoints Halliburton CEO Jeff Miller to boardFlowers Foods Q1 2026 EPS Beat, Revenue MissDirector Buys $29,316 in StockLeyla & Arzu Aliyeva Visit Urban ExpoArm CFO sells $7.23 million in shares